All Stories

  1. Tracking the invisible: Impact of disease-modifying therapies on serum neurofilament light chain and clinical outcomes in treatment-naïve multiple sclerosis
  2. Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study
  3. Platinum and Taxane-Induced Neuropathy and Its Impact on Quality of Life: A Single Institution Study.
  4. Mutations in the Key Autophagy Tethering Factor EPG5 Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism
  5. Nerve ultrasound as an adjunct to nerve conduction studies in Guillain–Barré syndrome diagnosis: a prospective Egyptian case–control study
  6. APOE, Sex, and Alzheimer’s Disease: Investigating Their Interplay in the Egyptian Population
  7. Sleep disorders in a sample of Egyptian patients with Parkinson's disease: a case–control polysomnography study
  8. APOE genetic variability in an Egyptian cohort of PD
  9. Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis
  10. Correction: Outcomes and safety of mechanical thrombectomy, alteplase, and conventional medical care in the treatment of acute M2 segment middle cerebral artery occlusion: a comparative study
  11. Outcomes and safety of mechanical thrombectomy, alteplase, and conventional medical care in the treatment of acute M2 segment middle cerebral artery occlusion: a comparative study
  12. Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum
  13. In PD, Non-Invasive Trans-Spinal Magnetic Stimulation Enhances the Effect of Transcranial Magnetic Stimulation on Axial Motor Symptoms: A Double-Blind Randomized Clinical Trial
  14. Effects of transcranial magnetic stimulation on sleep quality in fibromyalgia: A double-blind randomized clinical trial
  15. Mechanical thrombectomy of acute ischemic stroke of Medium Sized Vessels (M2 segment of middle cerebral artery occlusion)
  16. The impact of sex differences on stroke risk factors and 3-month outcomes in patients receiving thrombolytic therapy for acute ischemic stroke
  17. Impact of COVID-19 pandemic on the care of people with epilepsy and predictors of epilepsy worsening: Aswan/upper Egypt hospital-based study
  18. The Impact of Sex Differences on Stroke Risk Factors and 3-Month Outcomes in Patients Receiving Thrombolytic Therapy for Acute Ischemic Stroke
  19. Prevalence and determinants of post-stroke psychosis in Aswan: a prospective study
  20. Case report: Avoidant/restrictive food intake disorder after tonsillectomy
  21. Mutations in EPG5 are associated with a wide spectrum of neurodevelopmental and neurodegenerative disorders
  22. Impact of COVID-19 Pandemic on the Care of People with Epilepsy and Predictors of Epilepsy Worsening: Aswan/Upper Egypt Hospital-based study
  23. Short-Term Therapeutic Effect of Repetitive Transcranial Magnetic Stimulations of Sleep Disorders in Parkinson’s Disease: A Randomized Clinical Trial (Pilot Study)
  24. Determining Optimal Cut-Off Value For Ultrasound-Measured Median Nerve Cross-Sectional Area For Diagnosis Of Carpal Tunnel Syndrome In A Sample Of Egyptian Population
  25. Impact of COVID-19 Pandemic on Patients with Tension-Type Headache
  26. The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders
  27. Biallelic variation in the choline and ethanolamine transporterFLVCR1underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders
  28. The role of infections and inflammation in schizophrenia: review of the evidence
  29. Bridging the gap: associations between gut microbiota and psychiatric disorders
  30. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial
  31. Predictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study
  32. Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants
  33. Cerebrovascular reactivity after functional activation of the Brain using Photic Stimulation in Migraine and Tension Type Headache: a transcranial doppler Ultrasonography Study
  34. Myasthenia gravis with achalasia secondary to thymoma: a case report and literature review
  35. Relationship Between Disability and Psychiatric Outcome in Multiple Sclerosis Patients and Its Determinants
  36. Effets de la stimulation transcrânienne à courant direct sur la douleur et la consommation d’opioïdes après une chirurgie de la colonne vertébrale
  37. Effects of transcranial direct current stimulation in pain and opioid consumption after spine surgery
  38. Relationship between Attention Deficit Hyperactivity Disorder and epilepsy: a literature review
  39. Erratum to: Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia
  40. Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia
  41. Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
  42. Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
  43. Genetic and phenotypic characterization of NKX6‐2‐related spastic ataxia and hypomyelination
  44. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
  45. PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation
  46. An update on advances in magnetic resonance imaging of multiple system atrophy
  47. Clinical and Genetic analysis of Egyptian hereditary spastic paraplegia using next generation sequencing
  48. Genotype‐phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14
  49. Sequencing analysis of the SCA6 CAG expansion excludes an influence of repeat interruptions on disease onset
  50. Severe axonal neuropathy is a late manifestation of SPG11
  51. Genetic and phenotypic characterization of complex hereditary spastic paraplegia